Trieste, Italy

Luka Dordevic


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
2 patents (USPTO):

Title: **Luka Dordevic: Innovating Dopamine D2 Receptor Ligands**

Introduction

Luka Dordevic is an accomplished inventor based in Trieste, Italy. He holds two significant patents in the field of pharmacology, specifically focusing on dopamine D2 receptor ligands. His innovative work has important implications for the treatment and prevention of central nervous system and systemic disorders related to dopamine dysregulation.

Latest Patents

Dordevic's latest patents focus on novel dopamine D2 receptor ligands. These inventions relate to functionally-biased ligands that can be utilized for therapeutic purposes. Notably, one of his patents discusses compounds that not only modulate dopamine D2 receptors but also exhibit functional selectivity at these receptors. This selectivity extends downstream, affecting the β-arrestin pathway and the cAMP pathway. The applications of his work are critical in addressing various disorders associated with dopaminergic activity dysregulation.

Career Highlights

Throughout his career, Luka Dordevic has gained valuable experience working at prestigious institutions such as The Broad Institute and the Massachusetts Institute of Technology (MIT). His contributions to scientific research have been notable, particularly in understanding and developing compounds that can target specific receptor pathways in the brain.

Collaborations

Dordevic has collaborated with noteworthy individuals in the field, including Edward Holson and Florence Fevrier Wagner. These collaborations have helped enhance the quality and reach of his innovative work, driving forward the research related to dopamine receptor modulation.

Conclusion

Luka Dordevic's contributions to the field of pharmacology through his patents on dopamine D2 receptor ligands are significant. His innovative approach to targeting these receptors presents exciting possibilities for effective treatments for disorders related to dopamine dysregulation. As research continues to evolve, his work remains vital in paving the way for new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…